86
Participants
Start Date
September 20, 2007
Primary Completion Date
November 26, 2008
Study Completion Date
November 26, 2008
SB-751689
SB-751689
Placebo
Placebo to match
GSK Investigational Site, Buenos Aires
GSK Investigational Site, Quilmes
GSK Investigational Site, Rosario
GSK Investigational Site, Bryanston
GSK Investigational Site, St Leonards
GSK Investigational Site, Kogarah
GSK Investigational Site, Geelong
GSK Investigational Site, San Juan
GSK Investigational Site, Pinelands
GSK Investigational Site, Prague
GSK Investigational Site, Prague
GSK Investigational Site, Bucharest
GSK Investigational Site, Santiago de Compostela
GSK Investigational Site, Madrid
GSK Investigational Site, Taichung
GSK Investigational Site, Seville
GSK Investigational Site, Moscow
GSK Investigational Site, Yaroslavl
GSK Investigational Site, Cluj-Napoca
GSK Investigational Site, Yekaterinburg
GSK Investigational Site, Ciudad Autónoma de Buenos Aires
GSK Investigational Site, Ciudad Autónoma de Buenos Aires
GSK Investigational Site, Mar del Plata
GSK Investigational Site, Hong Kong
GSK Investigational Site, Naciones Unidas 346
GSK Investigational Site, Buenos Aires
GSK Investigational Site, Almelo
GSK Investigational Site, Amsterdam
GSK Investigational Site, Leiden
GSK Investigational Site, Seoul
GSK Investigational Site, Seoul
GSK Investigational Site, Gothenburg
GSK Investigational Site, Kungälv
GSK Investigational Site, Mölndal
GSK Investigational Site, Changhua
GSK Investigational Site, Rhyl
GSK Investigational Site, Edinburgh
Lead Sponsor
GlaxoSmithKline
INDUSTRY